Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.630
+0.140 (9.40%)
At close: Nov 22, 2024, 4:00 PM
1.640
+0.010 (0.61%)
After-hours: Nov 22, 2024, 4:06 PM EST
Aytu BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aytu BioPharma.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aytu BioPharma.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +206.75% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,126.99% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +7,261.96% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +6,034.97% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +13,396.93% | Apr 28, 2022 |
Financial Forecast
Revenue This Year
68.89M
from 81.00M
Decreased by -14.95%
Revenue Next Year
70.51M
from 68.89M
Increased by 2.35%
EPS This Year
0.23
from -2.86
EPS Next Year
0.43
from 0.23
Increased by 82.61%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.9M | 72.6M | 123.6M | ||
| Avg | 68.9M | 70.5M | 120.1M | ||
| Low | 66.2M | 67.7M | 115.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -12.4% | 5.4% | 75.3% | ||
| Avg | -15.0% | 2.4% | 70.3% | ||
| Low | -18.3% | -1.7% | 63.6% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.24 | 0.44 |
| Avg | 0.23 | 0.43 |
| Low | 0.23 | 0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 88.0% |
| Avg | - | 82.6% |
| Low | - | 75.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.